2000
Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV cost and services utilization study
Hays R, Cunningham W, Sherbourne C, Wilson I, Wu A, Cleary P, McCaffrey D, Fleishman J, Crystal S, Collins R, Eggan F, Shapiro M, Bozzette S. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV cost and services utilization study. The American Journal Of Medicine 2000, 108: 714-722. PMID: 10924648, DOI: 10.1016/s0002-9343(00)00387-9.Peer-Reviewed Original ResearchConceptsHealth-related qualityServices Utilization StudyHIV diseaseChronic diseasesPhysical functioningGeneral populationHIV CostUtilization studiesHuman immunodeficiency virus (HIV) diseaseHuman immunodeficiency virus (HIV) infectionSF-36 physical functioningMental health summary scoresMental healthAsymptomatic HIV diseaseImmunodeficiency virus infectionSymptomatic HIV diseaseWorse physical functioningHealth summary scoresUS general populationHealth insurance statusAttention of cliniciansCD4 countAdult patientsSubstantial morbidityImmunodeficiency syndrome
1986
Screening for HIV Infection: Risks, Benefits, and the Burden of Proof
Barry M, Cleary P, Fineberg H. Screening for HIV Infection: Risks, Benefits, and the Burden of Proof. The Journal Of Law, Medicine & Ethics 1986, 14: 259-267. PMID: 3475517, DOI: 10.1111/j.1748-720x.1986.tb00993.x.Peer-Reviewed Original Research
1982
The estimation and interpretation of modifier effects.
Cleary P, Kessler R. The estimation and interpretation of modifier effects. Journal Of Health And Social Behavior 1982, 23: 159-69. PMID: 7108181, DOI: 10.2307/2136512.Peer-Reviewed Original Research